News Details

Oct 15, 2018 | Dr Reddy’s to sell Hyderabad API unit to Therapiva

India’s leading drug maker Dr. Reddy’s Laboratories has decided to sell its active pharmaceutical ingredients (APIs) manufacturing facility located in Hyderabad’s Jeedimetla in favor of Therapiva, an emerging generics pharmaceutical firm. Therapiva is a joint venture between Omnicare Drugs India, a wholly-owned subsidiary of Abu Dhabi based Neopharma LLC, and Laxai Life Sciences

Back

Industry Expertise

News Details

Read More >>